SCHEMBL4692213

SCHEMBL4692213

CN(C)c1ccc(NC[C@@H](O)[C@@H](N)Cc2ccccc2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK1E P49674 1/20 0.45
ALDH1A1 P00352 4/20 0.44
MAPT P10636 3/20 0.44
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
ALOX15 P16050 1/20 0.44
NFKB1 P19838 1/20 0.44
MAPK1 P28482 1/20 0.44
NFKB2 Q00653 1/20 0.44
RELA Q04206 1/20 0.44
MCL1 Q07820 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
KMT2A Q03164 2/20 0.43
F2 P00734 2/20 0.42
MEN1 O00255 1/20 0.40
NOX1 Q9Y5S8 1/20 0.40
SLC15A1 P46059 1/20 0.40
CNR2 P34972 1/20 0.39
MAOA P21397 1/20 0.39
MAOB P27338 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4689485 0.85 CSNK1E (0.50) CSNK1EMAPTSMN1; SMN2F2SLC15A1
SCHEMBL4692605 0.85 HTT (0.50) CSNK1EALDH1A1MAPTMAPK1F2
SCHEMBL4694780 0.82 CSNK1E (0.44) CSNK1EALDH1A1MAPTNPC1RAB9A
SCHEMBL4695907 0.81 F2 (0.47) CSNK1EALDH1A1MAPTRAB9AMAPK1
SCHEMBL23093131 0.77 SLC6A4 (0.52) CSNK1ENPC1RAB9AKMT2AF2
SCHEMBL23092416 0.77 SLC6A4 (0.52) CSNK1ENPC1RAB9AKMT2AF2
SCHEMBL23092415 0.77 SLC6A4 (0.52) CSNK1ENPC1RAB9AKMT2AF2
SCHEMBL4695052 0.76 ALDH1A1 (0.45) CSNK1EALDH1A1MAPTNPC1RAB9A
SCHEMBL4307947 0.75 BACE1 (0.53)
SCHEMBL14416465 0.75 CSNK1E (0.55) CSNK1EF2SLC15A1MAOAEPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1692143-B1 TRICYCLIC INDOLE HYDROXYETHYLAMINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF ALZHEIMER'S DISEASE GLAXO GROUP LTD (GB) 2008-11-12 EP disclosed